Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Stroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excit...

Full description

Bibliographic Details
Main Authors: Qianwen Yang, Qianyi Huang, Zhiping Hu, Xiangqi Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Neuroscience
Subjects:
ROS
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.01036/full
id doaj-86d2f1045df24411b8dfd5d2327b928f
record_format Article
spelling doaj-86d2f1045df24411b8dfd5d2327b928f2020-11-25T02:47:35ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-09-011310.3389/fnins.2019.01036447291Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and InflammationQianwen YangQianyi HuangZhiping HuXiangqi TangStroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excitotoxicity, both of which contribute to rapid cell death within the infarct core. A subsequent cascade of inflammatory events escalates damage progression. This review explores potential neuroprotective strategies for targeting key steps in the cascade of ischemia–reperfusion (I/R) injury. NADPH oxidase (NOX) inhibitors and several drugs currently approved by the U.S. Food and Drug Administration including glucose-lowering agents, antibiotics, and immunomodulators, have shown promise in the treatment of stroke in both animal experiments and clinical trials. Ischemic conditioning, a phenomenon by which one or more cycles of a short period of sublethal ischemia to an organ or tissue protects against subsequent ischemic events in another organ, may be another potential neuroprotective strategy for the treatment of stroke by targeting key steps in the I/R injury cascade.https://www.frontiersin.org/article/10.3389/fnins.2019.01036/fullexcitotoxicityinflammationneuroprotectivepotential treatmentROSstroke
collection DOAJ
language English
format Article
sources DOAJ
author Qianwen Yang
Qianyi Huang
Zhiping Hu
Xiangqi Tang
spellingShingle Qianwen Yang
Qianyi Huang
Zhiping Hu
Xiangqi Tang
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
Frontiers in Neuroscience
excitotoxicity
inflammation
neuroprotective
potential treatment
ROS
stroke
author_facet Qianwen Yang
Qianyi Huang
Zhiping Hu
Xiangqi Tang
author_sort Qianwen Yang
title Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
title_short Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
title_full Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
title_fullStr Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
title_full_unstemmed Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
title_sort potential neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2019-09-01
description Stroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excitotoxicity, both of which contribute to rapid cell death within the infarct core. A subsequent cascade of inflammatory events escalates damage progression. This review explores potential neuroprotective strategies for targeting key steps in the cascade of ischemia–reperfusion (I/R) injury. NADPH oxidase (NOX) inhibitors and several drugs currently approved by the U.S. Food and Drug Administration including glucose-lowering agents, antibiotics, and immunomodulators, have shown promise in the treatment of stroke in both animal experiments and clinical trials. Ischemic conditioning, a phenomenon by which one or more cycles of a short period of sublethal ischemia to an organ or tissue protects against subsequent ischemic events in another organ, may be another potential neuroprotective strategy for the treatment of stroke by targeting key steps in the I/R injury cascade.
topic excitotoxicity
inflammation
neuroprotective
potential treatment
ROS
stroke
url https://www.frontiersin.org/article/10.3389/fnins.2019.01036/full
work_keys_str_mv AT qianwenyang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation
AT qianyihuang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation
AT zhipinghu potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation
AT xiangqitang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation
_version_ 1724752731034353664